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In this issue of Cell, Grunewald et al. (2006) examine the role of hematopoietic cells in the form­
ation of new blood vessels. They show that organ­specific expression of vascular endothelial 
growth factor (VEGF) is sufficient to mobilize and recruit hematopoietic cells from the bone 
marrow to the blood, but retention of the proangiogenic subpopulation of hematopoietic 
cells in peripheral organs requires an additional factor, stromal­derived factor 1 (SDF­1).It  has  been  generally  accepted  that 
after  birth,  the  growth  of  new  blood 




ing  that  cells  derived  from  the  bone 
marrow  may  also  contribute  to  post-
natal angiogenesis. Most studies have 
focused initially on delineating the role 
of  endothelial  progenitor  cells  in  this 
process.  However,  more  recent  data 
also support a model in which cells of 








from  the  bone marrow  has  remained 
an outstanding question.  In  this  issue 
of Cell,  Grunewald  et  al.  (2006)  pro-
pose  that  vascular  endothelial  growth 
factor  (VEGF)  recruits  a  heterogene-
ous mix of myeloid cells from the bone 
marrow to the blood, and a chemokine 
stromal-derived  factor-1  (SDF-1)  traps 
and  correctly  positions  a  subpopula-
tion of circulating proangiogenic mye-
loid cells around the growing vessels in 
tissues  (Figure  1).  The  proangiogenic 
cells promote endothelial cell sprouting 




tion of  bone marrow-derived cells—in 18  Cell 124, January 13, 2006 ©2006 Elseaddition  to  their mobilization—may be 
a key step  in  regulating adult neovas-
cularization.  In  another  paper  in  this 
issue  of Cell,  Foo  et  al.  (2006)  report 
that  ephrin-B2  regulates  the  retention 







cells  and  smooth  muscle  cells.  How 
then are hematopoietic cells relevant to 
endothelial cell sprouting? In fact, there 






nels  that  are  not  lined  by  endothelial 
cells but rather are lined by hemocytes, 
a  cell  type  belonging  to  the  hemat-
opoietic lineage. By analogy, the blood 
and blood vascular systems as well as 
hematopoiesis  and  angiogenesis  are 
also intimately intertwined in mammals. 
Blood  vessel  cells  and  hematopoietic 
cells are not only in close physical prox-
imity when  they  arise during develop-
ment,  but  the  endothelial  and  hemat-
opoietic progenitors may even share a 
common ancestor, the hemangioblast. 
In  the  embryo,  hematopoietic  stem 
cells migrate  into avascular  areas and 
attract  sprouting  endothelial  cells  by 
releasing  angiogenic  factors,  such  as 













and  dendritic  cells  have  even  main-
tained  some  of  the  ancient  plasticity 
of hemocytes and are able to transdif-
ferentiate into endothelial-like cells. In a 
reciprocal manner,  endothelial  cells  in 
the  bone marrow may  provide  a  vas-
cular niche for quiescent hematopoietic 
stem  cells,  and  regulate  the  prolifera-
tion of myeloid progenitors.
Thus,  a  number  of  hematopoietic 
cell  types affect blood vessel growth, 
in many cases by releasing angiogenic 





these  cells  at  these  peripheral  sites. 
We  know  that  angiogenic  agents 
such  as  VEGF,  placental  growth  fac-
tor (PlGF, a VEGF homolog) and angi-
opoietins, as well as chemokines and 
cytokines,  such  as  monocyte  chem-
oattractant protein-1  (MCP-1), stromal 
cell-derived  factor-1  (SDF-1),  granulo-
cyte/macrophage  colony  stimulating 
factor  (GM-CSF),  granulocyte  colony 
stimulating factor (G-CSF), erythropoi-
etin,  interleukins  (IL-3,  -8,  -17), Gro-β, 
and others can mobilize cells from the 
bone marrow  to  the  peripheral  blood 
(Carmeliet and Luttun, 2001; Orimo et 
al., 2005; Urbich and Dimmeler, 2004). 
However,  the  nature  of  the  signals  in 










expression  in  these  organs  induces 
robust  angiogenesis  by  stimulating 
endothelial cell proliferation (Grunewald 
et al., 2006). Based on our knowledge 
of  this  prototypic  angiogenic  factor, 
this  finding was not at all unexpected 
and,  at  first  sight,  would  seem  to  be 
attributable  to a direct effect of VEGF 
on  endothelial  cells.  However,  upon 
closer inspection, the authors noticed, 
surprisingly, that these tissues became 
infiltrated  with  abundant  bone  mar-
row-derived  monocytic  cells,  which 
they  termed  “recruited  bone marrow-
derived  circulating  cells”  (or  RBCCs) 
(Figure  1).  RBCCs  were  already 
present within 4 days, which is before 
the  growth  of  new  blood  vessels. 
These  RBCCs  did  not  appear  to  be 
endothelial  progenitor  cells,  because 
they did not  line the vessel wall as do 






used  their  genetic  model  to  address 
this question in more detail.
In  response  to mobilization  signals, 
such as VEGF, a heterogeneous mix of 
hematopoietic  cells  (progenitors  and 
more committed cells alike) is mobilized 
from the bone marrow to the peripheral 
blood.  Traditionally,  researchers  have 
tried  to  characterize  the  fraction  of 
such circulating bone marrow-derived 
cells  that  are  capable  of  stimulating 
tissue revascularization and regenera-







(MMP-9) and other angiogenic factors.distinct  lineage  markers  and  recep-
tors (e.g., CD45, CD133, CD14, CD34, 
CD117, VEGFR-1, and others) (Rafii and 
Lyden,  2003;  Urbich  and  Dimmeler, 
2004).  As  different  subpopulations 
may  have  such  activity,  and  complex 
combinations of several markers (often 
expressed  in  a  strain-specific  and  an 
activation-dependent  manner)  must 
be used, variable and often conflicting 






or heart. They  reasoned  that only  the 
proangiogenic  circulating  bone  mar-Cell 124, row-derived cells would be entrapped 
and correctly positioned around grow-
ing  vessels  in  these  organs  when 
stimulating  angiogenesis—thus  taking 
advantage  of  the  functional  filter  built 
in  by  nature.  The  RBCCs  expressed 
VEGFR-1,  explaining  why  they  were 




lized  from  the  bone  marrow  into  the 
peripheral blood, a selection of angio-
competent  bone  marrow-derived 
myeloid  cells  seemed  to  be  retained 
in  peripheral  tissues  in  response  to 
VEGF. Because VEGF expression was 
upregulated  uniformly  throughout  the January 13, 2006 ©2006 Elsevier Inc.  19





When  analyzing  the  gene  expres-
sion profile of the RBCCs, the authors 
noticed that the vast majority of these 
recruited  cells  expressed  CXCR4,  a 
receptor  for  the  chemokine  CXCL12, 
also  known  as  SDF-1  (Grunewald  et 
al.,  2006).  Indeed,  SDF-1  was  mini-
mally  expressed  in  quiescent  tissues, 
but when VEGF expression was turned 
on  experimentally  via  the  conditional 
genetic switch, the expression of SDF-
1  increased  markedly  in  perivascular 
fibroblasts  and  smooth  muscle  cells. 
SDF-1 was  also  induced  in  ischemic, 
inflamed,  and  malignant  tissues  in  a 
VEGF-dependent  manner.  Moreover, 
the  CXCR4  inhibitor  AMD3100  abro-
gated the entrapment of RBCCs in tis-
sues  overexpressing  VEGF.  Although 
RBCCs  showed  a  strong  chemotac-
tic  response  to  SDF-1  in  vitro,  over-




egress  of  RBCCs  from  VEGF-overex-
pressing  tissues  when  VEGF  expres-




Grunewald  et  al.  (2006)  also  pro-
vide evidence that RBCCs are  indeed 
angio-competent cells by showing that 
isolated  RBCCs  (or  their  conditioned 
medium)  stimulated  vessel  sprouting 
in  vitro,  and preventing  their  retention 
using  the  CXCR4  inhibitor  blocked 
angiogenesis  in  vivo.  Further  analysis 
revealed  that RBCCs  release MMP-9, 
a proteinase that facilitates endothelial 
cell  sprouting;  additional  angiogenic 
factors  are  also  likely  to  be  released. 
Moreover,  transplantation  of  RBCCs 
augmented  neovascularization  during 
the  healing  of  skin  wounds,  provid-
ing  strong  evidence  that  RBCCs  are 
angio-competent.
As is often the case, innovative con-
cepts  raise  questions.  For  instance, 
what  other  factors  besides  SDF-1 
retain angio-competent bone marrow-
derived cells in peripheral tissues? Are 20  Cell 124, January 13, 2006 ©2006 Elseproangiogenic cells also entrapped by 
other  signals,  such as  those  involved 
in the retention of hematopoietic stem 
cells  in  the  bone  marrow  or  those 
that  retain  other  tissue  progenitors 
in  their  niches?  Candidate  retention 
signals  include  membrane-bound  Kit 
ligand that binds to the cKit  receptor, 
fibronectin  and  VCAM-1  that  bind  to 
β1  integrins,  and  angiopoietin-1  that 
interacts  with  Tie-2,  to  name  a  few 




contrast  to  the findings  in  the Grune-
wald  study,  others  have  shown  that 
SDF-1  is  also  a  mobilization  signal, 
capable  of  recruiting  CXCR4-positive 
progenitor  cells  into  hypoxic  tissues 
(Ceradini et al., 2004). Does ischemia 
induce  other  signals  that  modify  the 
activitiy of SDF-1? What is the precise 
interplay  between  mobilization  sig-
nals (which recruit cells from the bone 
marrow  into  the  blood)  and  entrap-
ment  signals  (which  capture  cells  in 
tissues)?  Considering  the  similarities 
between  hematopoiesis  and  angio-
genesis,  do  other  cytokines  such  as 
GM-CSF,  G-CSF,  erythropoietin,  and 
thrombopoietin  also  recruit  RBCCs? 
And what  is  the association between 
endothelial  cells  and  CXCR4,  whose 
expression is upregulated in ischemia: 
does this provide another amplification 
mechanism  to  stimulate  endothelial 
cell  growth  when  SDF-1  expression 
increases?
The  elegant  study  by  Grunewald 
et  al.  (2006)  supports  the  emerging 
concept  that  an  optimal  angiogenic 
response not only relies on angiogenic 
signals  that  are  released  locally,  but 
also requires amplification of this local 
response  by mobilization  and  entrap-
ment  of  an  angio-competent  sub-
population of circulating bone marrow-
derived  support  cells,  which  release 
additional  angiogenic  factors.  This 







esis in pathological conditions. Indeed, vier Inc.recent  studies  reveal  that  anti-SDF-1 
antibodies  reduce  neovascularization 
in the eye (Butler et al., 2005).
There  are  other  examples  of  cell 
retention  in  the  vasculature.  Pericytes 
and  smooth  muscle  cells,  together 
known  as  mural  cells,  are  entrapped 
around  endothelial  cells  and  have  an 
accessory  role  in  vessel  growth  (for 
instance,  by  releasing  SDF-1)  as  well 
as  in  vessel  maturation  and  stability 
(Carmeliet, 2003). Progenitors of these 
mural cells are recruited to the nascent 
vasculature,  where  they  differentiate 
and make close contact with and cover 
up  endothelial  cells.  Previous  stud-




paper  in  this  issue  of Cell,  Foo  et  al. 
(2006)  provide  genetic  evidence  that 
the  expression  of  ephrin-B2  (a  ligand 
for Eph receptor tyrosine kinases; Car-
meliet  and  Tessier-Lavigne,  2005)  by 
mural cells is important for their normal 
positioning and retention around blood 
vessels.  In  the  absence of  ephrin-B2, 
hypermotile smooth muscle cells show 
numerous lammelipodial protrusions in 






vasculature:  ephrins  provide  guided 
navigation  and  contact  formation, 
whereas  SDF-1  provides  a  retention 
signal.  Regardless  of  the mechanistic 
details, studies such as Grunewald et 
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De  Palma,  M.,  Venneri,  M.A.,  Galli,  R.,  Sergi, The  identification  of  downstream  tar-
gets  of  regulatory  factors  is  required 
to  understand  cellular  responses  to 
environmental  and  developmental 
cues. Precise control of gene expres-
sion  is  achieved  through  regulators 
such as microRNAs and transcription 
factors  (He and Hannon, 2004; Pabo 




This  domain  allows  the  transcription 
factor  to  bind  to  specific DNA motifs 
in  the vicinity of  target genes.  In  the-
ory,  the  availability  of  whole  genome 
sequences should have made the job 
of  finding  transcription  factor  targets 
straightforward, for example, by allow-
ing  the  location  of  recognition motifs 
to be simply looked up in the genome 
sequence.  In  practice,  the  task  of 
determining transcription factor targets 
is  still  daunting,  especially  for  organ-
isms  with  complex  genomes.  Two 
papers  in  this  issue  of  Cell  (Hallikas 
Transcription F
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of  transcription  factors  and  their  cor-
responding  regulatory  regions.  The 
studies  focus on  transcription  factors 
that  are  important  for  development 
and  oncogenesis.  The  results  under-
score  the  importance  of  such  work 
and indicate that there is still much to 
be  discovered  about  even  well-char-
acterized  transcription  factors.  Addi-
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cloning  to  identify  the  corresponding 
transcription  factors.  The  availabil-
ity  of  whole  genome  sequences  has 
reversed  this  process  and  has made 
it possible to develop more exhaustive 
search methods.
The  first  contribution  of  whole 
genome  sequences  for  finding  tran-
scription  factor  targets has been  the 
development  of  microarray  technol-
ogy  to  measure  mRNA  expression 
(Young,  2000).  This  can  identify  all 
genes that exhibit significant changes 
in  mRNA  levels  upon  inactivation  of 
a  transcription  factor.  The  degree 
to  which  all  direct  targets  are  found 
depends  on  functional  redundancy 
and  whether  the  particular  devel-
opmental  stage  or  growth  condition 
being  studied  completely  covers  the 
role  of  the  transcription  factor.  The 
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